Join
Live feed
·
PRReleasevia Quantisnow
Altamira Therapeutics Ltd. logo

Altamira Therapeutics Announces Publication of Preclinical Data Showing Successful Treatment of Abdominal Aortic Aneurysm with SOD2 mRNA Delivered by SemaPhore Nanoparticles

ByQuantisnow·Wall Street's wire, on your screen.
CYTO· Altamira Therapeutics Ltd.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CYTO (Altamira Therapeutics Ltd.) and more on Quantisnow.